PACS vs. NHC, ENSG, RDNT, IOVA, ITGR, BHVN, AXSM, INSM, SMMT, and PBH
Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include National HealthCare (NHC), The Ensign Group (ENSG), RadNet (RDNT), Iovance Biotherapeutics (IOVA), Integer (ITGR), Biohaven (BHVN), Axsome Therapeutics (AXSM), Insmed (INSM), Summit Therapeutics (SMMT), and Prestige Consumer Healthcare (PBH). These companies are all part of the "medical" sector.
National HealthCare (NYSE:NHC) and PACS Group (NYSE:PACS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings, valuation and community ranking.
PACS Group has a consensus price target of $31.00, indicating a potential upside of 9.89%. Given National HealthCare's higher possible upside, analysts clearly believe PACS Group is more favorable than National HealthCare.
PACS Group received 10 more outperform votes than National HealthCare when rated by MarketBeat users.
National HealthCare has a net margin of 6.95% compared to National HealthCare's net margin of 0.00%. PACS Group's return on equity of 6.28% beat National HealthCare's return on equity.
In the previous week, PACS Group had 23 more articles in the media than National HealthCare. MarketBeat recorded 26 mentions for PACS Group and 3 mentions for National HealthCare. PACS Group's average media sentiment score of 0.48 beat National HealthCare's score of 0.26 indicating that National HealthCare is being referred to more favorably in the media.
56.4% of National HealthCare shares are owned by institutional investors. 13.8% of National HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
National HealthCare has higher revenue and earnings than PACS Group.
Summary
National HealthCare beats PACS Group on 7 of the 11 factors compared between the two stocks.
Get PACS Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PACS Group Competitors List
Related Companies and Tools
